Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730647 | SCV000858398 | uncertain significance | not provided | 2017-11-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003892627 | SCV004714601 | likely pathogenic | SLC10A1-related disorder | 2024-01-13 | no assertion criteria provided | clinical testing | The SLC10A1 c.132C>A variant is predicted to result in premature protein termination (p.Cys44*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in SLC10A1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |